InsiderTrades

Form 4 for AXGN Axogen, Inc.

Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-01 · accession 0000805928-22-000069 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-06-03 2022-06-01 AXGN THOMAS PAUL Dir A - Grant $0.00 +3,036 3,036 New $0
D 2022-06-03 2022-06-01 AXGN THOMAS PAUL Dir M - OptEx $0.00 -3,036 0 -100% $0
DM 2022-06-03 2022-06-01 AXGN THOMAS PAUL Dir A - Grant $0.00 +18.3K 6,459 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-01 A A 3,036 $0.00 3,036 D — — (F1) This reflects the number of restricted stock units that vested on June 1, 2022.
2 Derivative Restricted Stock Units 2022-06-01 M D 3,036 $0.00 0 D — · — to — 3,036 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F3) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date.
3 Derivative Stock Option (right to purchase) 2022-06-01 A A 11,811 $0.00 11,811 D $9.29 · — to 2032-06-01 11,811 Common Stock (F4) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.
4 Derivative Restricted Stock Units 2022-06-01 A A 6,459 $0.00 6,459 D — · — to — 6,459 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F4) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.